IMVT-1402-2505: A Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease (clinicaltrialsregister.eu) - May 7, 2026 - P1/2 | N=33 | Not yet recruiting | Sponsor: Immunovant Sciences GmbH
New P1/2 trial • Endocrine Disorders • Grave's Disease
|